Dear Doctor: Your patient is off his/her medication

Sending provider letters is associated with a significant impact on medication adherence

This study looked at members taking drugs in the three CMS Star rating categories: diabetes, high cholesterol and high blood pressure. When some of those members became non-adherent, their doctors were sent letters. A significant percentage of the members (up to 16%) whose doctors received letters became adherent again. This simple intervention provided an effective result.

Impact of provider mailings on medication adherence in Medicare Part D members (Spring 2014)

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit www.primetherapeutics.com and www.magellanrx.com, or follow us on Twitter at @Prime_PBM and @Magellan_Rx.

Dear Doctor: Your patient is off his/her medication

Sending provider letters is associated with a significant impact on medication adherence

Impact of provider mailings on medication adherence in Medicare Part D members (Spring 2014)

About Prime Therapeutics

Related news

Specialty Drug Pipeline Quarterly Update: September 2023

Traditional Drug Pipeline Quarterly Update: September 2023

Gene/Cell Therapy Quarterly Update: September 2023